Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation

Utilization and Outcomes of Measuring FFR in Patients With Stable Ischemic Heart Disease

January 28, 2020

Presentation

Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI

October 03, 2017

AEGIS-I Trial: The Safety and Tolerability of CSL112

Presentation AHA 2016

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

Presenter: Michael Gibson

November 15, 2016

Presentation

The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After PCI: The ADAPT-DES Study

Presenter: Sorin Brener

July 05, 2016

Presentation

Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically-Treated Diabetics

Presenter: Elvin Kedhi

July 05, 2016

Presentation

Stem Cell Therapy for Ischemic Cardiomyopathy

Presenter: Muzammil Mushtaq

October 31, 2015

Presentation

Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes

Presenter: BM. Everett BM

August 14, 2015

Presentation

Long-term Effects of Ischemic Postconditioning on Clinical Outcomes

Presenter: J-Y Hahn

March 13, 2015

Presentation TCT 2014

Impact of Ischemic Post-Conditioning on Infarct Size and Clinical Outcomes in Primary Percutaneous Coronary Intervention: A Meta-analysis of 26 Randomized Controlled Trials

Presenter: Alok Saurav

September 16, 2014

Presentation

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Presenter: Sripal Bangalore

April 22, 2014

Presentation

Remote Ischemic Postconditioning During PCI

Presenter: Shahar Lavi

April 09, 2014

Presentation

Ischemic Outcomes After Coronary Intervention of Calcified Vessels in ACS

Presenter: P. G?n?reux

February 19, 2014

Presentation

Effect of Remote Ischemic Preconditioning (IPC) on Platelet Activation and Reactivity Induced by Ablation for A-Fib

Presenter: A. Stazi

December 09, 2013

Presentation TCT 2013

How Do Different Systems of STEMI Care Attempt to Minimize Total Ischemic Time? United States, Europe, and Asia Practices

Presenter: William French

October 30, 2013

Presentation

POST: Ischemic Postconditioning During Primary Percutaneous Coronary Intervention

Presenter: J-Y Hahn

September 27, 2013

Presentation

CRISP: Remote Ischemic Preconditioning Improves Outcome at 6 Years After Elective PCI

Presenter: 212604|Will Davies

June 11, 2013

Presentation

What is the Best Initial Management Strategy for Stable Ischemic Heart Disease?

Presenter: 218868|Judith Hochman

May 31, 2013

Presentation

Hemorrhagic and Ischemic Outcomes After Bivalirudin vs. Heparin During CAS

Presenter: Siddharth A. Wayangankar

April 19, 2013

Presentation

Renoprotective Effect of Remote Ischemic Postconditioning by Intermittent Balloon Inflations in Patients Undergoing PCI

Presenter: S. Deftereos

March 13, 2013

Presentation TCT 2013

Remote Ischemic Perconditioning Improves Long-Term Clinical Outcome in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

Presenter: Astrid D Sloth, Michael R Schmidt, Kim Munk, Rajesh K Kharbanda, Andrew N Redington, Lars Pedersen, Henrik T S?rensen, Hans Erik B?tker

January 31, 2013

Advertisement

Utilization and Outcomes of Measuring FFR in Patients With Stable Ischemic Heart Disease

Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI

The Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Human ApoA-I, After Acute Myocardial Infarction: The ApoA-I Event reducingG in Ischemic Syndromes I Trial (AEGIS-I)

The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After PCI: The ADAPT-DES Study

Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically-Treated Diabetics

Stem Cell Therapy for Ischemic Cardiomyopathy

Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes

Long-term Effects of Ischemic Postconditioning on Clinical Outcomes

Impact of Ischemic Post-Conditioning on Infarct Size and Clinical Outcomes in Primary Percutaneous Coronary Intervention: A Meta-analysis of 26 Randomized Controlled Trials

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Remote Ischemic Postconditioning During PCI

Ischemic Outcomes After Coronary Intervention of Calcified Vessels in ACS

Effect of Remote Ischemic Preconditioning (IPC) on Platelet Activation and Reactivity Induced by Ablation for A-Fib

How Do Different Systems of STEMI Care Attempt to Minimize Total Ischemic Time? United States, Europe, and Asia Practices

POST: Ischemic Postconditioning During Primary Percutaneous Coronary Intervention

CRISP: Remote Ischemic Preconditioning Improves Outcome at 6 Years After Elective PCI

What is the Best Initial Management Strategy for Stable Ischemic Heart Disease?

Hemorrhagic and Ischemic Outcomes After Bivalirudin vs. Heparin During CAS

Renoprotective Effect of Remote Ischemic Postconditioning by Intermittent Balloon Inflations in Patients Undergoing PCI

Remote Ischemic Perconditioning Improves Long-Term Clinical Outcome in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content